Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Evaluation of Saglio G, Kim D-W, Issaragrisil S, et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 2010;362:2251-9, and
about
Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Evaluation of Saglio G, Kim D-W, Issaragrisil S, et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 2010;362:2251-9, and
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Are there better Bcr-Abl kinas ...... ngl J Med 2010;362:2251-9, and
@en
Are there better Bcr-Abl kinas ...... ngl J Med 2010;362:2251-9, and
@nl
type
label
Are there better Bcr-Abl kinas ...... ngl J Med 2010;362:2251-9, and
@en
Are there better Bcr-Abl kinas ...... ngl J Med 2010;362:2251-9, and
@nl
prefLabel
Are there better Bcr-Abl kinas ...... ngl J Med 2010;362:2251-9, and
@en
Are there better Bcr-Abl kinas ...... ngl J Med 2010;362:2251-9, and
@nl
P2860
P1476
Are there better Bcr-Abl kinas ...... ngl J Med 2010;362:2251-9, and
@en
P2093
Anne-Marie Christensen
Sheila A Doggrell
P2860
P304
P356
10.1517/14656566.2011.534780
P407
P577
2010-11-26T00:00:00Z